Ciprofloxacin treatment in preterm neonates in Bangladesh: Lack of effects on growth and development

ASM Nawshad Uddin Ahmed, Naila Z. Khan, Samir K. Saha, MAK Azad Chowdhury, Humaira Muslima, Paul Law, Maksuda Islam, Mallika Bhattacharya, Gary L. Darmstadt

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Quinolone-induced arthropathic toxicity in weight-bearing joints observed in juvenile animals during preclinical testing has largely restricted the routine use of ciprofloxacin in the pediatric age group. As histopathologic, radiologic and magnetic resonance imaging monitoring evidence has gathered supporting the safety of fluoroquinolones in children, many pediatricians have started to prescribe quinolones to some patients on a compassionate basis. OBJECTIVE: The objective of this study was to ascertain the safety of ciprofloxacin in preterm neonates

Original languageEnglish (US)
Pages (from-to)1137-1141
Number of pages5
JournalPediatric Infectious Disease Journal
Volume25
Issue number12
DOIs
Publication statusPublished - Dec 2006

    Fingerprint

Keywords

  • Arthropathy
  • Ciprofloxacin
  • Development
  • Fluoroquinolone
  • Follow up
  • Growth
  • Neonatal
  • Preterm
  • Sepsis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Microbiology (medical)

Cite this

Ahmed, ASM. N. U., Khan, N. Z., Saha, S. K., Chowdhury, MAK. A., Muslima, H., Law, P., ... Darmstadt, G. L. (2006). Ciprofloxacin treatment in preterm neonates in Bangladesh: Lack of effects on growth and development. Pediatric Infectious Disease Journal, 25(12), 1137-1141. https://doi.org/10.1097/01.inf.0000245105.99934.5f